Compare the Immune Response & Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine vs Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis & Dialysis Patients Who Did Not Respond to Previous Hepatitis B Vaccination

Inclusion criteria * A male or female subject greater than or equal to 15 years of age at the time of study entry * Written informed consent obtained from the subject/ from the parent or guardian of the subject. * Seronegative for anti-HBc antibodies and for HBsAg at screening. * Pre-dialysis patients, peritoneal dialysis patients or haemodialysis patients * Documented evidence of previous hepatitis B vaccination with at least one full primary vaccination course of minimum four injections of licensed vaccine. * The last dose should have been administered at least two months before the planned first dose of study vaccine in this study. * Documented evidence of non-response to previous hepatitis B vaccination after at least one to maximum three months after the last vaccine dose. Exclusion criteria * Subject included on HN014/HBV-001 study. History of Hepatitis B infection Use of immunoglobulins within six months preceding the first study vaccination. * Any confirmed or suspected human immunodeficiency virus (HIV) infection. Pregnant or lactating female